A Randomized Phase II Trial of Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer

Grant

Total Award Amount

  • 208271.00
  • Direct Costs

  • 140250.00
  • Sponsor Award Id

  • R21CA259808
  • Contributor

  • Andrew McDonald   Principal Investigator